Natixis Advisors
MDLN icon

Natixis Advisors’s Medline Inc MDLN Stock Holding History

Natixis Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9M Buy
479,049
+22,619
+5% +$911K 0.02% 555
2026
Q1 		$20.3M Buy
456,430
+345,341
+311% +$15.2M 0.03% 488
2025
Q4 		$4.67M Buy
+111,089
New +$4.69M 0.01% 838

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Lone Pine Capital
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Natixis Advisors's MDLN Position: Q2 2026 in Review

Natixis Advisors increased its Medline Inc (MDLN) stake by 5% in Q2 2026, buying an estimated $911K and bringing the position to 479,049 shares worth $18.9M. The position accounts for 0.02% of the portfolio, ranked #555.

Natixis Advisors first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.3M in Q1 2026. 409 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Natixis Advisors held 479,049 shares of Medline Inc worth $18.9M as of Q2 2026.
  • Natixis Advisors bought 22,619 Medline Inc shares in Q2 2026, an estimated $911K.
  • Medline Inc made up 0.02% of Natixis Advisors's portfolio in Q2 2026, its #555 holding.
  • Natixis Advisors first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • Natixis Advisors's Medline Inc position peaked at $20.3M in Q1 2026.
  • 409 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.